RK
Ragini Kudchadkar
Medical Oncology
Credentials: · · · ·
History
- 2010–2012
Medical Oncology
- 2007–2010
Internal Medicine
- 1999–2003
Research
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
New England Journal of Medicine · 2012 · 2,234 citations
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
New England Journal of Medicine · 2017 · 1,823 citations
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
New England Journal of Medicine · 2018 · 1,083 citations
26 papers
18 papers
- KL
17 papers
- JW
15 papers
12 papers
- NK
12 papers
- RG
11 papers
8 papers
